 Pablo Zuanic, analyst at Cantor Fitzgerald, offered an updated investment model for OrganiGram TSE: OGI NASDAQ:OGI for which he maintained an Overweight but lowered the 12-month price target for the stock to C5.30 from C5.70, owing to the increased share count. The Thesis 